← All Catalyst Pharmaceuticals, INC filings

Catalyst Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
CPRX
Catalyst Pharmaceuticals, INC
DEF 14A: Catalyst Pharmaceuticals Seeks Stockholder Approval for Director Elections, Stock Incentive Plan Amendment, Executive Compensation, and Auditor Ratification
Catalyst Pharmaceuticals is holding its 2025 Annual Meeting of Stockholders on May 20, 2025, to vote on key proposals including the election of directors, an amendment to the 2018 Stock Incentive Plan, executive compensation, and the ratification of its independent auditor.
NASDAQ
CPRX
Catalyst Pharmaceuticals, INC
DEF 14A: Catalyst Pharmaceuticals Seeks Stockholder Approval for Incentive Plan Amendment and Executive Compensation
Catalyst Pharmaceuticals is holding its annual meeting to elect directors, approve an amendment to its stock incentive plan, provide advisory approval of executive compensation, and ratify its accounting firm.